Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $22.87M | $0.55 | $13.00 | 2,280.95% | Strong Buy | 2 | N/A | N/A | -5,552.75% | -343.38% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $6.80M | $4.29 | $95.50 | 2,126.11% | Buy | 2 | N/A | N/A | -1,395.33% | -808.10% | |||
| IOBT | IO BIOTECH INC | $23.91M | $0.36 | $8.00 | 2,103.86% | Strong Buy | 2 | N/A | N/A | -786.27% | -29.57% | |||
| KALA | KALA BIO INC | $9.87M | $1.53 | $32.67 | 2,035.10% | Buy | 3 | N/A | N/A | -893.03% | -105.64% | |||
| FEMY | FEMASYS INC | $9.59M | $0.35 | $7.00 | 1,888.64% | Strong Buy | 2 | 159.81% | N/A | -122.78% | -18.46% | |||
| ATYR | ATYR PHARMA INC | $64.17M | $0.72 | $13.63 | 1,789.74% | Buy | 4 | N/A | N/A | 21.74% | 16.78% | |||
| MRSN | MERSANA THERAPEUTICS INC | $38.73M | $7.76 | $140.00 | 1,704.12% | Strong Buy | 2 | 12.06% | N/A | N/A | -12.89% | |||
| GOVX | GEOVAX LABS INC | $12.00M | $0.47 | $8.50 | 1,697.04% | Strong Buy | 2 | N/A | N/A | 4,539.42% | 2,393.57% | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $77.01M | $4.36 | $61.50 | 1,310.55% | Strong Buy | 4 | N/A | N/A | 796.95% | 436.51% | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $28.77M | $0.50 | $6.50 | 1,200.00% | Buy | 2 | 299.93% | N/A | N/A | -188.43% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $203.05M | $0.67 | $8.33 | 1,138.19% | Strong Buy | 3 | 8.11% | N/A | 92.35% | 18.56% | |||
| FGEN | FIBROGEN INC | $49.54M | $12.25 | $146.50 | 1,095.92% | Buy | 2 | N/A | N/A | N/A | -19.10% | |||
| PSTV | PLUS THERAPEUTICS INC | $67.50M | $0.68 | $7.88 | 1,058.09% | Strong Buy | 4 | 41.35% | N/A | 359.89% | 105.50% | |||
| GRI | GRI BIO INC | $5.18M | $2.06 | $22.50 | 992.23% | Buy | 2 | N/A | N/A | -26.50% | -15.51% | |||
| NRXP | NRX PHARMACEUTICALS INC | $65.03M | $3.30 | $34.50 | 945.45% | Strong Buy | 4 | N/A | N/A | -276.64% | 2,036.49% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $37.27M | $2.56 | $26.67 | 941.68% | Buy | 3 | 405.49% | N/A | N/A | N/A | |||
| MDCX | MEDICUS PHARMA LTD | $41.24M | $2.32 | $23.50 | 915.12% | Strong Buy | 2 | N/A | N/A | -82.26% | -22.39% | |||
| PMN | PROMIS NEUROSCIENCES INC | $22.28M | $0.43 | $4.33 | 907.67% | Strong Buy | 3 | N/A | N/A | -2,302.04% | 92.61% | |||
| OSTX | OS THERAPIES INC | $62.51M | $1.96 | $19.50 | 894.90% | Strong Buy | 2 | N/A | N/A | 90.32% | 43.30% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.81M | $1.04 | $10.00 | 861.54% | Strong Buy | 2 | N/A | N/A | -71.37% | -60.18% | |||
| MTVA | METAVIA INC | $22.75M | $0.94 | $9.00 | 857.45% | Strong Buy | 3 | N/A | N/A | -279.09% | -145.51% | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $10.21M | $5.32 | $50.00 | 839.85% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| CING | CINGULATE INC | $21.22M | $3.92 | $36.50 | 831.12% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| INTS | INTENSITY THERAPEUTICS INC | $11.44M | $0.24 | $2.25 | 825.93% | Strong Buy | 2 | N/A | N/A | -517.12% | -254.19% | |||
| KAPA | KAIROS PHARMA LTD | $24.27M | $1.17 | $10.50 | 797.44% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $22.53M | $2.62 | $23.50 | 796.95% | Strong Buy | 2 | 240.34% | N/A | -33.23% | -29.08% | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.14M | $5.09 | $45.00 | 784.09% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| MYO | MYOMO INC | $33.72M | $0.89 | $7.83 | 778.14% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $25.09M | $0.37 | $3.20 | 767.21% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| JSPR | JASPER THERAPEUTICS INC | $38.68M | $2.38 | $20.14 | 746.34% | Buy | 7 | N/A | N/A | -387.30% | -195.88% | |||
| CRDL | CARDIOL THERAPEUTICS INC | $88.46M | $1.07 | $9.00 | 741.12% | Buy | 2 | N/A | N/A | 158.27% | 93.74% | |||
| SLN | SILENCE THERAPEUTICS PLC | $244.90M | $5.19 | $42.60 | 720.81% | Buy | 5 | 8.38% | N/A | N/A | -94.33% | |||
| NOTE | FISCALNOTE HOLDINGS INC | $66.44M | $4.63 | $37.50 | 709.94% | Strong Buy | 2 | -11.65% | N/A | -33.81% | -11.15% | |||
| IPSC | CENTURY THERAPEUTICS INC | $43.02M | $0.50 | $4.00 | 703.21% | Strong Buy | 2 | N/A | N/A | -40.33% | -29.74% | |||
| IMUX | IMMUNIC INC | $84.51M | $0.88 | $7.00 | 693.65% | Strong Buy | 4 | N/A | N/A | N/A | -200.84% | |||
| MBRX | MOLECULIN BIOTECH INC | $16.05M | $0.53 | $4.00 | 654.72% | Buy | 2 | N/A | N/A | N/A | -67.32% | |||
| PASG | PASSAGE BIO INC | $25.53M | $8.03 | $59.25 | 637.86% | Strong Buy | 4 | N/A | N/A | -8.89% | -4.29% | |||
| TIL | INSTIL BIO INC | $120.57M | $17.86 | $125.00 | 599.89% | Buy | 2 | N/A | N/A | -32.66% | -18.62% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.92M | $9.45 | $65.00 | 587.83% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| ACET | ADICET BIO INC | $66.99M | $0.81 | $5.50 | 579.01% | Strong Buy | 2 | N/A | N/A | -47.64% | -40.22% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $111.99M | $0.87 | $5.88 | 577.62% | Buy | 2 | N/A | N/A | -51.49% | -46.05% | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.40M | $5.13 | $34.75 | 577.39% | Strong Buy | 2 | 17.65% | N/A | -2.15% | -1.01% | |||
| ANVS | ANNOVIS BIO INC | $40.34M | $2.07 | $13.50 | 552.17% | Strong Buy | 2 | N/A | N/A | -160.52% | -137.15% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $275.13M | $1.24 | $8.00 | 545.16% | Strong Buy | 7 | N/A | N/A | -46.15% | -33.79% | |||
| SNTI | SENTI BIOSCIENCES INC | $36.77M | $1.41 | $8.50 | 502.84% | Strong Buy | 2 | N/A | N/A | -55.11% | -25.21% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.